—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Veracyte Inc (VCYT) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for VCYT, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 1.06 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How VCYT has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.06 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Veracyte Inc moved 1.06% on average · correlation 0.15 · higher than 89% of US names
  • Beta, last 3 months 1.25 about the same as over the year
  • On the 10 worst bond days −0.13% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +10.77% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Diagnostics & Research · US · 7 names with week and year-to-date

Peer group

Diagnostics & Research · US

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against VCYT on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Veracyte Inc

VCYT in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Veracyte runs genomic diagnostic tests that help doctors decide on treatment for thyroid, prostate, bladder, breast and lung conditions, reading tissue and nasal-swab samples through its own sequencing and analysis platforms. It also supplies instrument services built on the nCounter analysis system. The company is based in South San Francisco and sells its tests to clinicians in the United States and abroad.
Where it sits in the stack
Veracyte carries no seat in our index, so it sits outside the AI build-out stack; within our universe it belongs to the Diagnostics & Research sleeve of the Healthcare sector.
Who it is priced against
No peer group is recorded for Veracyte in the diary; the name the market most often sets alongside it is Exact Sciences, another genomic diagnostics company.
Why Closelooknet tracks it
Veracyte holds no index seat and carries no Closelooknet score yet, and it has not appeared in any of the diary's quoted editions so far.
What the diary watches
The diary watches whether Veracyte's recent share weakness, which our chart note shows running below both its short- and long-term averages, steadies or extends as its test volumes move through reimbursement decisions.

Veracyte Inc (VCYT) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Veracyte Inc (VCYT)?

Veracyte Inc trades as VCYT on the US exchange (US) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is VCYT in a Closelooknet index?

Not currently — Veracyte Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does VCYT trade against its moving averages?

Pullback inside an uptrend stack: Trades -1.7% vs the 50-day and +7% vs the 200-day average, 25.4% below the 52-week high and +54.2% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Veracyte Inc trade when bond yields rise?

Over the past year Veracyte Inc had a beta of 1.06 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 89% of US names. On the 10 sessions in which long bonds fell most it moved −0.13% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Veracyte Inc do?

Veracyte runs genomic diagnostic tests that help doctors decide on treatment for thyroid, prostate, bladder, breast and lung conditions, reading tissue and nasal-swab samples through its own sequencing and analysis platforms. It also supplies instrument services built on the nCounter analysis system. The company is based in South San Francisco and sells its tests to clinicians in the United States and abroad. No peer group is recorded for Veracyte in the diary; the name the market most often sets alongside it is Exact Sciences, another genomic diagnostics company.

Where does Veracyte Inc sit in the AI build-out?

Veracyte carries no seat in our index, so it sits outside the AI build-out stack; within our universe it belongs to the Diagnostics & Research sleeve of the Healthcare sector. Veracyte holds no index seat and carries no Closelooknet score yet, and it has not appeared in any of the diary's quoted editions so far.

What does this page show?

A live price chart with SMA overlays and drawing tools for VCYT, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.